Clinical and pathological features of patients with resected synovial sarcoma: A multicenter retrospective analysis of the Anatolian Society of Medical Oncology


Tarkan Y., Erkan A., Selcuk E. S., Mehmet K., Tugba K. F., Ozlem U. S., ...More

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, vol.10, no.1, pp.73-78, 2014 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 10 Issue: 1
  • Publication Date: 2014
  • Doi Number: 10.4103/0973-1482.131381
  • Journal Name: JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.73-78
  • Keywords: Ki-67, mitotic activity, synovial sarcoma, PROGNOSTIC-FACTORS, TENDOSYNOVIAL SARCOMA, CHEMOTHERAPY, OUTCOMES, TUMORS, EXTREMITIES, SURVIVAL
  • Dokuz Eylül University Affiliated: Yes

Abstract

Background: Synovial sarcoma (SS) is a rare disease and compared with other soft-tissue sarcomas has a relatively high mortality rate. The optimal management of this disease and prognostic factors associated with patient outcome remains controversial.